Pharmaceutical Industry Reports Streptozocin Market | Page 2

REPORT DESCRIPTION
Streptozocin Market – Overview
Streptozocin is a drug approved by U.S. Food and Drug Administration (USFDA) for the treatment of
pancreatic islet cells cancer. Streptozocin is classified as an alkylating agent, which produces anti-cancer
effects by causing a chemical reaction that damages the DNA in a cell. The DNA damage caused by
streptozocin results in the cell death. Streptozocin damages pancreatic cells causing hyperglycemia, so, also
used in medical research to produce an animal model for hyperglycemia.
Increasing research activities using streptozocin is expected to propel growth of the streptozocin market
during the forecast period. For instance, an article published in the journal Nature in February 2018, stated
that streptozocin may reduce the virulence of Staphylococcus aureus. It is a Gram-positive human
pathogen, which colonizes at skin and other mucosal surface and causes various diseases ranging from skin
and soft-tissue infections, endocarditis, toxic shock syndrome, and necrotizing pneumonia. The virulence
gene in the bacteria can be targeted by streptozocin.